Technology

New Strong Sell Stocks for April 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BioScrip, Inc. BIOS is an infusion and home care management solutions provider. The Zacks Consensus Estimate for its current year earnings has been revised 22.2% downward over the last 30 days.

Briggs & Stratton Corporation BGG is a manufacturer of gasoline engines for outdoor power equipment. The Zacks Consensus Estimate for its current year earnings has been revised 16% downward over the last 30 days.

Champions Oncology, Inc. CSBR is a technology solutions and products provider, whose products and solutions are used to personalize the development and use of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.

Cronos Group Inc. CRON is a principal investment firm. The Zacks Consensus Estimate for its current year earnings has been revised 81.8% downward over the last 30 days.

Dean Foods Company DF is a food and beverage company. The Zacks Consensus Estimate for its current year earnings has been revised 30% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Click to get this free report

Dean Foods Company (DF): Free Stock Analysis Report

Briggs & Stratton Corporation (BGG): Free Stock Analysis Report

Champions Oncology, Inc. (CSBR): Free Stock Analysis Report

BioScrip, Inc. (BIOS): Free Stock Analysis Report

Cronos Group Inc. (CRON): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Technology Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More